 Research
 Open access
 Published:
Effects of prolactin on bone remodeling process with parathyroid hormone supplement: an impulsive mathematical model
Advances in Difference Equations volume 2017, Article number: 147 (2017)
Abstract
In this paper, we investigate the effect of prolactin on bone remodeling process with the impulsive supplement of parathyroid hormone. An impulsive mathematical model is developed and analyzed theoretically in order to obtain the conditions on the parameters of the model for which the net bone formation might be expected from the parathyroid hormone supplement. Numerical investigation is also carried out to confirm our theoretical predictions. The dosage and the frequency of parathyroid hormone supplement turned out to be the keys for the effective parathyroid hormone supplement.
1 Introduction
Osteoporosis is a metabolic bone disease detected mostly in postmenopausal women and is recognized as a major health problem in many countries. It is characterized mainly by low bone mass [1–3]. Nowadays, the population of those aged over 60 years is increasing rapidly in Thailand, and hence, osteoporosis is then becoming more prevalent in Thailand. Osteoporosis occurs when bone remodeling process, the process that normally occurs throughout life to control the repair or replacement of bone following injuries, is imbalanced with a net bone resorption greater than bone formation at bone multicellular units (BMUs) [1–3]. Bone remodeling process consists of bone resorption, for which osteoclasts are responsible, and bone formation, for which osteoblasts are responsible [1–3].
There are several hormones involved in bone remodeling process including prolactin (PRL). It has been reported that PRLreceptors have been found on osteoblasts [4]. Moreover, PRL has also been reported to enhance bone resorption in part by increasing receptor activator of NFligand (RANKL) and decreasing osteoprotegerin (OPG) expressions by osteoblasts [5]. On the other hand, the increase in the number of osteoclasts results in the increase in calcium level in blood and the secretion of parathyroid hormone (PTH), one of the principal hormones that regulate calcium levels in blood to vary in the normal ranges, from the parathyroid gland is then decreased [1–3]. The decrease in the PTH level then results in the reduction of PRL secretion from the anterior pituitary gland because PTH normally inhibits the reuptake and release of dopamine (DA) which is PRL inhibiting factor [1–3, 6].
Drug treatments in osteoporosis patients will slow down the activity of bone resorbing cells (osteoclasts) or stimulate the activity of bone forming cells (osteoblasts) or do both. PTH supplement is an option for treating osteoporosis patients. PTH has effects on both bone resorbing cells and bone forming cells [1–3]. As reported in [7], PTH at a high level inhibits the production of bone resorbing cells while it has both stimulating and inhibiting effects on the production of bone forming cells depending on the stage of the development of bone forming cells. In addition, the studies of [7–9] showed the paradoxical results of net bone formation and net bone loss when PTH is administered in a different manner. Hence, more insightful study on the effects of PTH supplements on bone remodeling process is needed.
Even though several mathematical models of bone remodeling process were proposed and analyzed theoretically and numerically [7, 10–14], the model that incorporates the effects of PRL and the impulsive treatments of PTH has not been proposed and analyzed yet. In the next section, we develop an impulsive mathematical model to investigate bone remodeling process based on the effects of PRL and the impulsive PTH supplement.
2 An impulsive mathematical model
Let \(x(t)\) denote the concentration of PRL above the basal level in blood at time t, \(y(t)\) denote the number of active osteoclasts at time t and \(z(t)\) denote the number of active osteoblasts at time t. We then propose an impulsive mathematical model to incorporate the effects of PRL and PTHsupplement on bone remodeling as follows:
with
where \(\Delta y(t)=y({{t}^{+}})y(t)\), \(\Delta z(t)=z({{t}^{+}})z(t)\), T represents the period of impulsive treatment of PTH, \(n\in {{Z}_{+}}\), \({{Z}_{+}}=\{1,2,3,\ldots\}\), ρ represents the inhibiting effect of PTH supplement on osteoclasts, \(0<\rho<1\), and μ represents the stimulating effect of PTH supplement on osteoblasts, \(\mu >0\). All parameters in the model are also assumed to be positive.
Equation (1a) represents the rate of change of PRL concentration in blood. As mentioned above, the increase in the number of active osteoclasts results in the increase in calcium level in blood, and the secretion of PTH from the parathyroid gland is then decreased [1–3]. The decrease in the PTH level then results in the reduction of PRL secretion from the anterior pituitary gland because of the inhibiting effect of PTH on the uptake and release of DA which is PRL inhibiting factor [1–3, 6]. Hence, the first term on the righthand side accounts for the secretion rate of PRL from the lactotroph cells in the anterior pituitary gland which is inhibited by the increase in the number of active osteoclasts. The last term on the righthand side represents the removal rate of PRL from the system.
Equation (1b) represents the rate of change of the number of active osteoclasts. Even though osteoclasts do not possess PRL receptors as osteoblasts as reported in [4], PRL has been reported to enhance bone resorption by increasing RANKL and decreasing OPG expressions by osteoblasts [5]. RANKL then binds to RANK, its receptor on preosteoclast, and stimulates proliferation and maturation into osteoclast. The first term on the righthand side then accounts for the stimulating effect of PRL on the production of active osteoclasts. The last term on the righthand side represents the removal rate of active osteoclasts from the system.
Equation (1c) represents the rate of change of the number of active osteoblasts. The first term on the righthand side accounts for the production of active osteoblasts depending on the production and differentiation of active osteoclasts. That is, the more active osteoclasts, the more active osteoblasts are needed to refill the resorption cavities on BMUs created by active osteoclasts [1–3]. The second term on the righthand side accounts for the inhibiting effect of PRL on the production of active osteoblasts which has been reported in [15]. The last term on the righthand side accounts for the removal rate of active osteoblasts from the system.
Since the dynamics of PRL is very fast compared to the changes in the number of active osteoclasts and active osteoblasts [1–3], we then assume in what follows that PRL equilibrates quickly to its equilibrium for which \(\frac{dx}{dt}=0\). That is,
System (1a)(1e) is then reduced to the following system:
with
In the next section, we state the definitions and lemmas needed to prove the main results.
3 Preliminaries
Let
where \({{R}_{+}}=[0,\infty)\), \({R}_{+}^{2}=\{S\in{{R}^{2}}:S=(y,z), y\ge 0, z\ge0\}\). The map defined by the righthand side of (3a)(3b) is denoted by \(F=({{F}_{1}},{{F}_{2}})\).
Definition 3.1
The function V defined in (4) is said to belong to class \({V_{0}}\) if

(a)
V is continuous in \((nT,(n+1)T]\times R_{+}^{2}\to{R_{+}}\) and for each \(S\in R_{+}^{2}\), \(n\in{Z_{+}}\), \(\lim_{(t,Y)\to(nT^{+},S)} V(t,Y)=V(nT^{+},S)\) exists, and

(b)
V is locally Lipschitzian in S.
Definition 3.2
Suppose \(V\in{V_{0}}\). For \((t,S)\in(nT,(n+1)T]\times R_{+}^{2}\), the upper right derivative of \(V(t,S)\) with respect to (4)(7) is defined by
where \(F=({F_{1}},{F_{2}})\).
Assume that the solution of (3a)(3d), \(S(t)=(y(t),z(t))\), is a piecewise continuous function. That is, \(S(t):{{R}_{+}}\to{R}_{+}^{2}\), \(S(t)\) is continuous on \((nT,(n+1)T]\), \(n\in{{Z}_{+}}\) and \(\lim_{t\to nT^{+}}S(t)=S(nT^{+})\) exists. Then the smoothness properties of F guarantee the global existence and uniqueness of solution to (3a)(3d).
Since \(\frac{dy}{dt}=0\) whenever \(y(t)=0\), \(t\ne nT\), \(\frac {dz}{dt}>0\) whenever \(z(t)=0\), \(t\ne nT\) and \(y(n{{T}^{+}})=(1\rho )y(nT)\), \(0<\rho<1\), \(z(n{{T}^{+}})=z(n{{T}})+\mu\), \(\mu>0\), the following lemmas are obtained.
Lemma 3.1
Suppose \(S(t)=(y(t),z(t))\) is a solution of (3a)(3d) with \(S({{0}^{+}})\ge0\). Then \(S(t)\ge0\) for all \(t\ge0\).
Lemma 3.2
There exists a constant \(M>0\) such that, for sufficiently large t, \(y(t)\le M\) and \(z(t)\le M\) provided that
where \((y(t),z(t))\) is a solution of (3a)(3d).
Proof
Let \(v(t)=y(t)+z(t)\), \({M_{1}}=\sup yf(y)=\frac{c_{1}}{d_{1}}\), and \({M_{2}}= c_{3}\).
For \(t\ne nT\), we choose a positive constant c for which \(c=\min \{d_{2},{d}_{3}\frac{{c_{1}}{c_{2}}}{{d_{1}}{k_{2}}} \}\).
Then
Therefore, \({{D}^{+}}v\lecv+{{M}_{2}}\).
For \(t=nT\),
According to Lemma 2.2 of Liu et al.[16], for \(t\in (nT,(n+1)T]\), we have
Hence, \(v(t)\) is uniformly ultimately bounded and there exists a constant \(M>0\) such that \(y(t)\le M\) and \(z(t)\le M\) for sufficiently large t. □
4 Stability in the absence of active osteoclasts
Let us consider the impulsive system (3a)(3d) in the absence of active osteoclasts \(y=0\), system (3a)(3d) becomes
where \(A\equiv\frac{{c_{1}}{c_{4}}}{{d_{1}}{k_{1}}{k_{4}}}+d_{3}\). Here \(A>0\), a periodic solution of (6)(8) is
with \(\tilde{z}(0^{+})=\frac{\mu}{1{e^{AT}}}\).
Hence, the positive solution of (6)(8) is
This leads to the following result.
Lemma 4.1
System (6)(8) has a positive periodic solution \(\tilde{z}(t)\), and for every solution \(z(t)\) of (6)(8), we have \(z(t)\to\tilde{z}(t)\) as \(t\to\infty\).
Therefore, system (3a)(3d) has a periodic solution in the absence of active osteoclasts:
for \(t\in(nT,(n+1)T]\) and \(\tilde{z}(nT^{+})=\tilde{z}(0^{+})=\frac{\mu }{1{e^{AT}}}\), \(n\in{Z_{+}}\). The conditions which guarantee the local stability of a periodic solution \((0,\tilde{z}(t))\) are then given in the following theorem.
Theorem 4.1
The solution \((0,\tilde{z}(t))\) of (3a)(3d) is locally asymptotically stable if
and
where
and \(D\equiv\frac {{c_{1}}{c_{2}}{d_{1}}{k_{1}}}{c_{1}^{2}+d_{1}^{2}k_{1}^{2}{{k}_{2}}}\).
Proof
Consider a small perturbation from the point \((0,\tilde{z}(t))\)
Then we may write
where \({\Phi}(t)\) satisfies
and \({\Phi}(0)=I\), the identity matrix.
Therefore, the fundamental solution matrix is
Note that it is not necessary to find the exact expression for (*) because the term (*) is not involved in further analysis.
Linearization of (3c)(3d) yields
Hence, Floquet theory implies that the solution \((0,\tilde{z}(t))\) of (3a)(3d) is locally stable if \(\vert \lambda_{i} \vert <1\), \(i=1,2\), where \(\lambda_{i}\) is an eigenvalue of
The eigenvalues of M are
Since \(0<\rho<1\), \(A>0\) and (10) holds, then
Hence,
and
Therefore, Floquet theory implies that the solution \((0,\tilde{z}(t))\) is locally stable and the proof is complete. □
In the next section, the permanence of impulsive system (3a)(3d) is investigated.
5 Permanence of the system
Definition 5.1
System (3a)(3d) is said to be permanent if there are constants \(m, M>0\) (independent of the initial values) and a finite time \({{t}_{0}}\) such that for all solutions with initial values \(y(0^{+})>0\), and \(z(0^{+})>0\),
for all \(t>{t_{0}}\). Note that \({t_{0}}\) may depend on the initial values.
Theorem 5.1
System (3a)(3d) is permanent if (5) and (11) hold and
Proof
Suppose that \(S(t)=(y(t),z(t))\) is a solution of system (3a)(3d) with \(y(0^{+})>0\) and \(z(0^{+})>0\). Since (5) holds, Lemma 3.2 implies that there is a constant \(M>0\) such that, for sufficiently large t, \(y(t)\le M\) and \(z(t)\le M\).
Since \(\frac{{c_{3}}y}{{k_{3}}+y}>0\) and \((\frac {{c_{4}}f(y)z}{{k_{4}}+f(y)}+{d_{3}} )\) is a decreasing function when \(y>0\), (3b) implies that
and then we have
for some \(\varepsilon>0\) and for sufficiently large t.
Thus,
for sufficiently large t.
Therefore, we only need to show that there exists a constant \({m_{2}}>0\) such that \(y(t)>{m_{2}}\). In order to do so, for some \({m_{3}}>0\), we first let
Next, we do the following two steps.
Step 1 We prove by contradiction that there exists \(t_{1}\) such that \(y(t_{1})\ge{m_{3}}\). Suppose that \(y(t)<{m_{3}}\) for all positive t. From (3b) and (3d)
Let us consider the comparison system
and
Therefore,
is a periodic solution of (14)(16) with \(P(0^{+})\equiv \frac{\mu}{1{e^{AT}}}>0\). The positive solution of (14)(16) is
and \(P(t)\to\tilde{P}(t)=\frac{\mu{e^{A(tnT)}}}{1{e^{AT}}}\), as \(t\to\infty\).
The comparison theorem [17] then implies that \(z(t)\geq P(t)\).
From (3a), we have
Since \(z(t)\geq P(t)\), there is \({T_{1}}>0\) such that
for sufficiently small \({\varepsilon_{1}} > 0\).
Hence,
and
Letting \(N\in Z_{+}\) and \(NT\ge T_{1}\) and integrating over \((nT,(n+1)T]\), \(n\ge N\), we obtain
where \(\eta\equiv(1\rho)\exp (\frac{{\hat{M}_{1}}\mu }{A}({\varepsilon_{1}}{\hat{M}_{1}}+{d_{2}})T )\).
Consider
For sufficiently small \({\varepsilon_{1}}>0\),
Since \({\hat{M}_{1}}< D\), \(\ln (\frac{1}{1\rho} )<\frac{D\mu }{A}\) and (11) hold, we can choose a small constant \({m_{3}}>0\) such that \(\eta>0\), and hence,
Then \(y((n+k)T)\ge y(nT)\eta^{k}\to\infty\) as \(k\to\infty\), which contradicts the boundedness of \(y(t)\). Hence, there is \(t_{1}>0\) such that \(y(t_{1})\ge{m_{3}}\).
Step 2 If \(y(t)\ge{m_{3}}\) for all \(t>{t_{1}}\), then the proof is complete. Otherwise, \(y(t)<{m_{3}}\) for some \(t>{t_{1}}\). Let \(t^{*}=\inf_{t>t_{1}}\{y(t)< m_{3}\}\). There are two possible subcases as follows.
Case 1: \({t^{*}}={n_{1}}T\) for some \({n_{1}}\in{Z_{+}}\). This means \(y(t)\ge {m_{3}}\) for \(t\in(t_{1},t^{*}]\) and, by the continuity of \(y(t)\), we have \(y(t^{*})={m_{3}}\).
Since there are \(M>0\) and \(m_{1}>0\) such that \(y(t)< M\) and \(m_{1}< z(t)< M\) for sufficiently large t, we choose \(M'>0\) and \(m'_{1}>0\) such that
and
such that
Then choose \(n_{2}, n_{3}\in Z_{+}\) such that
and
where
Let \(T'={n_{2}}T+{n_{3}}T\). We claim that there is \(t_{2} \in(t^{*},t^{*}+T']\) such that \(y(t_{2})>m_{3}\). Otherwise, considering (18) with \(P(t^{*+})=z(t^{*+})\), we have
for \(t\in(nT,(n+1)T]\) and \(n_{1}\le n\le n_{1}+n_{2}+n_{3}\).
For \({n_{2}}T\le tt^{*}\le T'\), we have
Therefore,
As in Step 1, we have
From (3a), we have
Integrating the above over \([t^{*},t^{*}+{n_{2}}T]\), we obtain
which contradicts the definition of \(m_{3}\). Hence, there is \(t_{2} \in (t^{*},t^{*}+T']\) such that \(y(t_{2})>m_{3}\).
Now, let \(\tilde{t}=\inf_{t>t^{*}}\{y(t)>m_{3}\}\). Then \(y(t)< {m_{3}}\) for \(t\in(t^{*},\tilde{t})\), and by the continuity of \(y(t)\), we have \(y(\tilde{t})={m_{3}}\). We choose \(l\in{Z_{+}}\) such that \(l\le{n_{2}}+{n_{3}}\) and \(t^{*}+lT\ge\tilde{t}\), and suppose \(t\in (t^{*}+(l1)T,t^{*}+lT]\). From (26), we have
Since \(\eta_{1}<0\) and \(l\le n_{2}+n_{3}\), letting
we have \(y(t)\ge\bar{m}_{2}\) for \(t\in(t^{*},\tilde{t})\). We can continue in the same way by using t̃ instead of \(t^{*}\). Then we shall have \(y(t)\ge\bar{m}_{2}\) for all t large enough.
Case 2: \(t^{*}\ne nT\) for all \(n\in{Z_{+}}\). This means \(y(t)\ge{m_{3}}\) for \(t\in[t_{1},t^{*})\) and \(y(t^{*})={m_{3}}\). Suppose \(t^{*} \in ({n'_{1}}T,({n'_{1}}+1)T)\) for some \({n'_{1}}\in{Z_{+}}\). There are two possible subcases as follows.
Case 2.1: \(y(t)\le{m_{3}}\) for all \(t\in(t^{*},({n'_{1}}+1)T]\). We claim that there is \({t'_{2}}\in[({n'_{1}}+1)T,({n'_{1}}+1)T+T']\) such that \(y(t'_{2})>{m_{3}}\). Otherwise, consider (18) with \(P(({n'_{1}}+1){T^{+}})=z(({n'_{1}}+1){T^{+}})\). For \(t\in(nT,(n+1)T]\), \({n'_{1}}+1\le n\le{n'_{1}}+1+{n_{2}}+{n_{3}}\), we obtain
Similar to Case 2.1, for \({n_{2}}T\le tt^{*}\), we obtain
Then
Since \({n_{2}}T\le(n'_{1}+1+n_{2})Tt^{*}\), we have
Then
which contradicts the definition of \(m_{3}\). Hence, there is \(t'_{2} \in [(n'_{1}+1)T,(n'_{1}+1)T+T']\) such that \(y(t'_{2})>m_{3}\).
Now, let \(\bar{t}=\inf_{t>t^{*}}\{y(t)>m_{3}\}\). Then \(y(t)\le m_{3}\) for \(t\in[t^{*},\bar{t})\), and \(y(\bar{t})=m_{3}\). We choose \(l'\in Z_{+}\) such that \(l'\le n_{2}+n_{3}+1\) and suppose \(t\in ({n'_{1}}T+(l'1)T,{n'_{1}}T+l'T]\). From (26), we have
Since \(\eta_{1}<0\) and \(tt^{*}\le l'T\). Hence,
Let
We have \(y(t)\ge m_{2}\) for \(t\in(t^{*},\bar{t})\). We can continue in the same manner by using t̄ instead of \(t^{*}\). Then we shall have \(y(t)\ge m_{2}\) for all t large enough.
Case 2.2: There is \(t''\in(t^{*},({n'_{1}}+1)T]\) such that \(y(t'')>{m_{3}}\). Let \(\underline{t}=\inf_{t>t^{*}}\{y(t)>m_{3}\}\). Hence, \(y(t)<{m_{3}}\) for \(t\in[t^{*},\underline{t})\), and \(y(\underline {t})={m_{3}}\). For \(t\in[t^{*},\underline{t})\), (26) holds, we have
since \(t<{n'_{1}}T+T<t^{*}+T\). For \(t>\underline{t}\), we can continue in the same manner since \(y(\underline{t})\ge m_{3}\). Since \(m_{2}<\bar {m}_{2}<m_{3}\), we have \(y(t)\ge m_{2}\) for \(t \ge t_{1}\). The proof is complete. □
6 Existence and stability of the positive periodic solution
We now investigate the possibility of bifurcation of a positive periodic solution to system (3a)(3d) near \((0,\tilde {z}(t))\). Let us exchange the state variables for convenience so that system (3a)(3d) becomes
with
Let
According to Lakmeche and Arini [18],
and
Here, we can compute
where \(\tau_{0}\) is the root of \(d'_{0}=0\). Note that \(d'_{0}>0\) if \(T>T_{\mathrm{max}} \) and \(d'_{0}<0\) if \(T< T_{\mathrm{max}} \).
Here, \(b'_{0}<0\) provided that
Since \((1\frac{A{\tau_{0}}}{1\exp(A{\tau_{0}})} )\) is always negative for \({\tau_{0}}>0\), then
and hence, \(B^{*}C^{*}<0\). According to Lakmeche and Arini [18], the following result is obtained.
Theorem 6.1
System (27)(30) has a positive periodic solution provided (5), (11), (31) hold, and \(T< T_{\mathrm{max}} \).
In the next section, numerical simulations are given in order to confirm our theoretical predictions.
7 Numerical results
To support our prediction in Theorem 4.1, we choose all parameters so that all the conditions in Theorem 4.1 are satisfied. The simulation result is as shown in Figure 1. We can see that the solution converges asymptotically to the oscillatory solution \((0,\tilde{z}(t))\) as predicted. The simulation result in Figure 2 is obtained from choosing all parameters to satisfy all the conditions in Theorem 5.1. In this case, we can see that the solution is bounded within a positive range as we expected as well. Finally, we also carry out numerical simulation to confirm our prediction in Theorem 6.1. The result is as shown in Figure 3 in which the solution trajectory tends toward the sustained oscillations when all parameters are chosen to satisfy all the conditions in Theorem 6.1.
8 Conclusion
The impulsive mathematical model is proposed to incorporate the effects of PRL and PTH supplement on bone remodeling process. The conditions on system parameters are then derived so that we can expect desirable behaviors of the solution of the system such as the solution will be bounded within a positive range, which means that the number of bone forming cells and bone resorbing cells is able to be controlled and lies within the appropriate levels.
From Theorem 5.1, one of the conditions used to guarantee the boundedness of the number of active osteoblasts and active osteoclasts is \(T< T_{\mathrm{max}} \), where \(T_{\mathrm{max}} \) depends on μ and ρ. We can see that, if the dosage of PTH supplement reflected by μ and ρ is fixed, we can choose an appropriate frequency of PTH supplement \(\frac {1}{T}\) for which \(T< T_{\mathrm{max}} \) as required by Theorem 5.1 to guarantee the appropriate levels of active osteoblasts and active osteoclasts. Moreover, Theorem 6.1 implies that if all the conditions required in Theorem 5.1 are satisfied and PRL is secreted from the anterior pituitary gland with the sufficient amount, i.e., \(c_{1}^{2}>d_{1}^{2} k_{1}^{2} k_{2}\), the oscillatory behavior resembling clinical observation can be expected. Hence, the frequency and dosage of PTH supplement are the keys to the effectiveness of PTH supplement in osteoporosis patients.
References
Goodman, HM: Basic Medical Endocrinology, 3rd edn. Academic Press, San Diego (2003)
Albright, JA, Sauders, M: The Scientific Basis of Orthopaedics. Appleton and Lange, Norwalk (1990)
Marcus, R: Osteoporosis. Blackwell Scientific Publication, Oxford (1994)
Lacroix, PC, Ormandy, C, Lepescheux, L, Ammann, P, Damotte, D, Goffin, V, Bouchard, B, Amling, M, Kelly, MG, Binart, N, Baron, R, Kelly, PA: Osteoblasts are a new target for prolactin: analysis of bone formation in prolactin. Endocrinology 140, 96105 (1999)
Charoenphandhu, N, Tudpor, K, Thongchote, K, Saengamnart, W, Puntheeranurak, S, Krishnamara, N: Highcalcium diet modulates effects of longterm prolactin exposure on the cortical bone calcium content in ovariectomized rats. Am. J. Physiol: Endocrinol. Metab. 292, E443E452 (2007)
Momsen, G, Schwarz, P: A mathematical/physiological model of parathyroid hormone secretion in response to bloodionized calcium lowering in vivo. Scand. J. Clin. Lab. Invest. 57, 381394 (1997)
Kroll, MH: Parathyroid hormone temporal effects on bone formation and resorption. Bull. Math. Biol. 62, 163188 (2000)
Tam, CS, Heersche, JNM, Murray, TM, Parsons, JA: Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration. Endocrinology 110(2), 506512 (1982)
Hock, JM, Gera, I: Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J. Bone Miner. Res. 7(1), 6572 (1992)
Chaiya, I, Rattanakul, C, Rattanamongkonkul, S, Kunpasuruang, W, Ruktamatakul, S: Effects of parathyroid hormone and calcitonin on bone formation and resorption: mathematical modeling approach. Int. J. Math. Comput. Simul. 6(5), 510519 (2011)
Rattanakul, C, Lenbury, Y, Krishnamara, N, Wollkind, DJ: Mathematical modelling of bone formation and resorption mediated by parathyroid hormone: responses to estrogen/PTH therapy. Biosystems 70, 5572 (2003)
Rattanamongkonkul, S, Kunpasuruang, W, Ruktamatakul, S, Rattanakul, C: A mathematical model of bone remodeling process: effect of vitamin D. Int. J. Math. Comput. Simul. 6(5), 489498 (2011)
Rattanakul, C, Rattanamongkonkul, S: Effect of calcitonin on bone formation and resorption: mathematical modeling approach. Int. J. Math. Models Methods Appl. Sci. 5(8), 13631371 (2011)
Rattanakul, C, Rattanamongkonkul, S, Kunpasuruang, W, Ruktamatakul, S, Srisuk, S: A mathematical model of bone remodeling process: effects of parathyroid hormone and vitamin D. Int. J. Math. Models Methods Appl. Sci. 5(8), 13881397 (2011)
Coss, D, Yang, L, Kuo, CB, Xu, X, Luben, RA, Walker, AM: Effects of prolactin on osteoblast alkaline phosphatase and bone formation in the developing rat. Am. J. Physiol: Endocrinol. Metab. 279, E1216E1225 (2000)
Liu, B, Zhi, Y, Chen, LS: The dynamics of a predatorprey model with Ivlev’s functional response concerning integrated pest management. Acta Math. Appl. Sin. 20(1), 133146 (2004)
Lakshmikantham, V, Bainov, DD, Simeonov, PS: Theory of Impulsive Differential Equations. World Scientific, Singapore (1989)
Lakmeche, A, Arini, O: Bifurcation of nontrivial periodic solutions of impulsive differential equations arising chemotherapeutic treatment. Dyn. Contin. Discrete Impuls. Syst. 7, 265287 (2000)
Acknowledgements
This work was supported by the Royal Golden Jubilee Ph.D. Program (contract number PHD53K0191), the Centre of Excellence in Mathematics, Commission on Higher Education, Thailand and Mahidol University, Thailand.
Author information
Authors and Affiliations
Corresponding author
Additional information
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
The first author analyzed the model theoretically. The second author developed the model and carried out numerical simulations. All authors read and approved the final manuscript.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Chaiya, I., Rattanakul, C. Effects of prolactin on bone remodeling process with parathyroid hormone supplement: an impulsive mathematical model. Adv Differ Equ 2017, 147 (2017). https://doi.org/10.1186/s136620171199x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s136620171199x